BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18234964)

  • 1. Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells.
    Braunstein S; Formenti SC; Schneider RJ
    Mol Cancer Res; 2008 Jan; 6(1):78-88. PubMed ID: 18234964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB in the Radiation Response of A549 Non-Small Cell Lung Cancer Cells to X-rays and Carbon Ions under Hypoxia.
    Nisar H; Sanchidrián González PM; Labonté FM; Schmitz C; Roggan MD; Kronenberg J; Konda B; Chevalier F; Hellweg CE
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.
    Drain AP; Zahir N; Northey JJ; Zhang H; Huang PJ; Maller O; Lakins JN; Yu X; Leight JL; Alston-Mills BP; Hwang ES; Chen YY; Park CC; Weaver VM
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33822843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.
    Bravatà V; Cava C; Minafra L; Cammarata FP; Russo G; Gilardi MC; Castiglioni I; Forte GI
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting inflammatory pathways for tumor radiosensitization.
    Deorukhkar A; Krishnan S
    Biochem Pharmacol; 2010 Dec; 80(12):1904-14. PubMed ID: 20599771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A target of potential RELAvance in inflammatory breast cancer.
    Eckhardt BL; Ueno NT
    Oncotarget; 2017 Apr; 8(16):25835-25836. PubMed ID: 28460487
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication.
    Saga R; Matsuya Y; Takahashi R; Hasegawa K; Date H; Hosokawa Y
    Sci Rep; 2021 Apr; 11(1):8258. PubMed ID: 33859324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular paradigms of multidrug resistance in cancer.
    Vaidya FU; Sufiyan Chhipa A; Mishra V; Gupta VK; Rawat SG; Kumar A; Pathak C
    Cancer Rep (Hoboken); 2022 Dec; 5(12):e1291. PubMed ID: 33052041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer.
    Mercogliano MF; Bruni S; Elizalde PV; Schillaci R
    Front Oncol; 2020; 10():584. PubMed ID: 32391269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the
    Jeong YJ; Oh HK; Choi HR
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular NME proteins: a player or a bystander?
    Romani P; Ignesti M; Gargiulo G; Hsu T; Cavaliere V
    Lab Invest; 2018 Feb; 98(2):248-257. PubMed ID: 29035383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
    Breunig C; Pahl J; Küblbeck M; Miller M; Antonelli D; Erdem N; Wirth C; Will R; Bott A; Cerwenka A; Wiemann S
    Cell Death Dis; 2017 Aug; 8(8):e2973. PubMed ID: 28771222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and -2 Coordinate Transcriptional and Translational Reprogramming in Resistance to DNA Damage and Replicative Stress in Breast Cancer Cells.
    Silvera D; Ernlund A; Arju R; Connolly E; Volta V; Wang J; Schneider RJ
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
    Stanley J; Klepczyk L; Keene K; Wei S; Li Y; Forero A; Grizzle W; Wielgos M; Brazelton J; LoBuglio AF; Yang ES
    Breast Cancer Res Treat; 2015 Apr; 150(3):569-79. PubMed ID: 25833211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
    Zhou J; Ching YQ; Chng WJ
    Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζ.
    Rimessi A; Patergnani S; Ioannidi E; Pinton P
    Front Oncol; 2013 Sep; 3():232. PubMed ID: 24062985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
    Sinha S; Ghildiyal R; Mehta VS; Sen E
    Cell Death Dis; 2013 May; 4(5):e615. PubMed ID: 23640457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B.
    Torres MA; Pace TW; Liu T; Felger JC; Mister D; Doho GH; Kohn JN; Barsevick AM; Long Q; Miller AH
    Cancer; 2013 Jun; 119(11):1951-9. PubMed ID: 23512358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.
    Curry MC; Luk NA; Kenny PA; Roberts-Thomson SJ; Monteith GR
    J Biol Chem; 2012 Aug; 287(34):28598-608. PubMed ID: 22733819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
    Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
    J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.